Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Drug Manufacturers
Indoco Remedies Ltd (BOM:532612) Q1 2025 Earnings Call Transcript Highlights: Revenue Decline Amid Strategic Growth Initiatives
Despite a dip in net revenue, Indoco Remedies Ltd (BOM:532612) focuses on new product launches and market expansions to drive future growth. Sep 13, 2024
Drug Manufacturers
Strides Pharma Science Ltd (BOM:532531) Q4 2024 Earnings Call Transcript Highlights: Record Revenues and Strategic Growth Plans
Strides Pharma Science Ltd (BOM:532531) reports its best year yet with significant growth in revenue, EBITDA, and strategic market expansions. Sep 13, 2024
Drug Manufacturers
Strides Pharma Science Ltd (BOM:532531) Q3 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Market Positioning
Strides Pharma Science Ltd (BOM:532531) reports 17% revenue growth, significant debt reduction, and robust market performance in Q3 2024. Sep 13, 2024
Drug Manufacturers
Granules India Ltd (BOM:532482) Q1 2025 Earnings Call Transcript Highlights: Robust Revenue Growth and Strategic Investments
Granules India Ltd (BOM:532482) reports a 20% YoY revenue increase and significant EBITDA growth, driven by strong performance in finished dosages and strategic investments. Sep 13, 2024
Drug Manufacturers
Ajanta Pharma Ltd (BOM:532331) Q4 2024 Earnings Call Transcript Highlights: Strong Revenue and Profit Growth Amid Operational Challenges
Ajanta Pharma Ltd (BOM:532331) reports robust financial performance with significant year-over-year increases in revenue and profit for Q4 FY24. Sep 13, 2024